Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Volta Medical, GE HealthCare Team Up for AI-Powered Electrophysiology - Medical Product Outsourcing
Financial & Business, OEM News

Volta Medical, GE HealthCare Team Up for AI-Powered Electrophysiology

The duo aims to combine their tech to support electrophysiologists during catheter ablation to treat AFib.

Volta Medical has entered a joint development agreement with GE HealthCare.

The collaboration entails Volta integrating its Volta AF-Xplorer artificial intelligence (AI) solutions with GE HealthCare’s Prucka 3 and CardioLab electrophysiology (EP) recording system. The combined technologies aim to boost performance and streamline workflows for electrophysiologists during catheter ablation to treat atrial fibrillation (AFib).

Volta’s AI solution assists with real-time assessment of dispersed electrograms (EGMs) and aligns with GE HealthCare’s CardioLab EP recording system’s signal clarity. By merging advanced EP recording and AI-driven dispersion info, the duo hopes to help optimize AFib management.

According to GE HealthCare’s global GM for Invasive Cardiology Devon Beam, access to large amounts of data empowers decision-making, but effectively utilizing the data at the point of care can be a challenge.

“As GE HealthCare continues to advance our innovation to provide clinicians with precise signals in the EP lab, Volta Medical’s AI-driven solutions hold promise in consolidating and simplifying data, as well as assisting clinicians in making treatment decisions for their patients,” Beam told the press. “I’m excited about our ongoing collaboration with Volta Medical as we work to innovate and transform electrophysiology labs to ensure patients receive the best possible care.”

The partnership follows a key Volta initiative after the Heart Rhythm Society 2024 meeting. There, investigators shared TAILORED-AF trial results that showed improved freedom from AFib in subjects treated with AI-guided ablation, compared to conventional anatomical ablation.

Volta is now targeting early commercialization efforts and completing its RESTART trial. RESTART is evaluating Volta’s AI ablation tool in recurrent-AFib patients who failed previous ablations.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters